ATOS Competitors

NSC

Atossa Therapeutics, Inc.

Healthcare•Diagnostics & Research

Peers:JNJ•LH•NEO•ENZ•DGX

$2.78

+$0.22 (+8.59%)

1Y Target

$17.00

+511.5%

Prev Close

$2.56

Open

$2.52

Volume

235.94K

Market Cap

$27.74M

52 Week Range

$1.70

$17.25

See all ETFs with ATOS

Prev Close:$2.56

Open:$2.52

Volume:235.94K

Market Cap:$27.74M

52 Week Range

$1.70

$17.25

See all ETFs with ATOS

40

MarketXLS Rank ®

60

Value ®

50

Technical

10

Quality

How is this score calculated?

ATOS Competitors

Atossa Therapeutics, Inc.

$2.78

+$0.22(+8.59%)

40

Overall

60

Value

50

Tech

10

Quality

How is this score calculated?

Market Cap

$27.74M

Volume

235.94K

52W Range

$1.70 - $17.25

Target Price

$17.00

ATOS competitors: JNJ, LH, NEO, ENZ, DGX. Atossa Therapeutics, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.

ATOS Competitors Compared

Company	Price	Market cap	EPS est. (current yr)	Dividend yield	MarketXLS Rank
JNJ Johnson & Johnson	$253.91	$599.12B	$11.09	2.08%	56
LH Labcorp Holdings Inc.	$317.34	$25.44B	$18.32	0.91%	69
NEO NeoGenomics, Inc.	$16.88	$2.17B	$-0.09	-	49
DGX Quest Diagnostics Incorporated	$233.43	$25.76B	$11.15	1.08%	65

Get Atossa Therapeutics, Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

BUY NOW

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ATOS	$2.78	+8.59%	235.94K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ATOS	$2.78	+8.6%	235.94K
3
4
5
6

Get Atossa Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW